Influence of plasma exchange on rituximab pharmacokinetics

被引：12

作者：

Azzopardi, Nicolas ^{[1
,2
]}

Francois, Maud ^{[3
]}

Laurent, Emeline ^{[4
]}

Paintaud, Gilles ^{[1
,2
,4
]}

Birmele, Beatrice ^{[3
]}

机构：

[1] CNRS, UMR 7292, F-75700 Paris, France

[2] Univ Tours, GICC, PRES Ctr Val Loire Univ, F-37032 Tours 01, France

[3] CHRU Tours, Dept Haemodialysis, Tours, France

[4] CHRU Tours, Dept Pharmacol Toxicol, Tours, France

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2013年 / 76卷 / 03期

关键词：

TRANSPLANTATION;

D O I：

10.1111/bcp.12167

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：486 / 488

页数：3

共 6 条

[1] Evaluation of a peptide ELISA for the detection of rituximab in serum [J].

Blasco, H. ;

Lalmanach, G. ;

Godat, E. ;

Maurel, M. C. ;

Canepa, S. ;

Belghazi, A. ;

Paintaud, G. ;

Degenne, D. ;

Chatelut, E. ;

Cartron, G. ;

Le Guellec, C. .

JOURNAL OF IMMUNOLOGICAL METHODS, 2007, 325 (1-2) :127-139

[2] Rituximab therapy for acute humoral rejection after kidney transplantation [J].

Faguer, Stanislas ;

Kamar, Nassim ;

Guilbeaud-Frugier, Celine ;

Fort, Marylise ;

Modesto, Anne ;

Mari, Arnaud ;

Ribes, David ;

Cointault, Olivier ;

Lavayssiere, Laurence ;

Guitard, Joelle ;

Durand, Dominique ;

Rostaing, Lionel .

TRANSPLANTATION, 2007, 83 (09) :1277-1280

[3] B cell depletion in autoimmune disease [J].

Gorman, C ;

Leandro, M ;

Isenberg, D .

ARTHRITIS RESEARCH & THERAPY, 2003, 5 (Suppl 4) :S17-S21

[4] Rituximab pharmacokinetics during the management of acute idiopathic thrombotic thrombocytopenic purpura [J].

McDonald, V. ;

Manns, K. ;

Mackie, I. J. ;

Machin, S. J. ;

Scully, M. A. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (06) :1201-1208

[5] Sequential blood level monitoring of basiliximab during multisession plasmapheresis in a kidney transplant recipient [J].

Nojima, M ;

Yoshimoto, T ;

Nakao, A ;

Itahana, R ;

Kyo, M ;

Hashimoto, M ;

Shima, H .

TRANSPLANTATION PROCEEDINGS, 2005, 37 (02) :875-878

[6] Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab [J].

Patriarca, F. ;

Medeot, M. ;

Isola, M. ;

Battista, M. L. ;

Sperotto, A. ;

Pipan, C. ;

Toffoletti, E. ;

Dozzo, M. ;

Michelutti, A. ;

Gregoraci, G. ;

Geromin, A. ;

Cerno, M. ;

Savignano, C. ;

Rinaldi, C. ;

Barbone, F. ;

Fanin, R. .

TRANSPLANT INFECTIOUS DISEASE, 2013, 15 (03) :259-267

← 1 →